|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
���� |
|
�Դ������� |
|
���� |
| ��������������� | |
|
���������� |
|
��������У |
| PubMed | |
|
Article by ���������� |
|
Article by ��������У |
�����ڼ��Դ��������Ĵ���
����������1, ��������У2
1. �й�ҽѧ��ѧԺƤ�����о���;
2. �й�Э��ҽ�ƴ�ѧƤ�����о���
�����ڼ��Դ��������Ĵ���Ӧ�ܵ��ر�����,��ԭ���������Դ����������и�������̥����DZ��Σ�ա�����,�и���δ�������Դ������������Ʒ�������Ч���ܲ�ͬ�����������������ڼ�÷�����������Ⱦ��ɳ����ԭ���Ⱦ����ֳ���������ë�γ��Ⱦ��ϸ�������������������Լ�����ʪ��Ĵ���
1. �й�ҽѧ��ѧԺƤ�����о���;
2. �й�Э��ҽ�ƴ�ѧƤ�����о���
1. �й�ҽѧ��ѧԺƤ�����о���;
2. �й�Э��ҽ�ƴ�ѧƤ�����о���
[2] Brocklehurst P.Update on the treatment of sexually transmitted infections in pregnancy-1.Int J STD AIDS,1999,10(9):571-580.
[3] Centers for Disease Control and Prevention.Guidelines and treatment of sexually transmitted diseases:MMWR recommendations and report.Atlanta(GA):US Department of Health and Human Services,1998.
[4] Alexander JM,Sheffield JS,Sanchez P J,et al.Efficacy of treatment for syphilis in pregnancy.Obstet Gynecol,1999,93(1):5-8.
[5] Donders GG,Desmyter J,Hooft P,et al.Apparent failure of one injection of benzathine penicillin G for syphilis during pregnancy in human immunodeficiency virus-seronegative African women.Sex Transm Dis,1997,24(2):94-101.
[6] Angela JR,Geoffrey LR.Concurrent gonococcal and chlamydial infection- how best to treat.Drugs,2000,59:801-813.
[7] Brown ZA,Selke S,Zeh J,et al.The acquisition of herpes simplex virus during pregnancy.N Engl J Med,1997,337(8):509-515.
[8] Smith JR,Cowan FM,Munday P.The management of herpes simplex virus infection in pregnancy.Br J Obstet Gynaecol,1998,105(3):255-260.
[9] Nahmias A J,Josey WE,Naib ZM,et al.Perinatal risk associated with maternal genital herpes simplex virus infection.Am J Obstet Gynecol,1971,110(6):825-837.
[10] Clinical Effectiveness Group.National guideline for the management of genital herpes.Sex Transm Infect,1999,75(Suppl 1):S24-S28.
[11] Reiff-Eldridge R,Heffner CR,Ephross SA,et al.Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries:a pharmaceutical company commitment.Am J Obstet Gynecol,2000,182(1 Pt 1):159-163.
[12] Brown Z,Hume RF,Selke S,et al.Subclinical shedding of herpes simplex virus at the time of labor.Presented at the annual meeting of the society of perinatal obstetricians.Miami Beach,FL,February 1998.
[13] Brown ZA.Genital herpes complicating pregnancy.Dermatol Clin,1998,16(4):805-810.
[14] Struthers BJ.Metronidazole appears not to be a human teratogen:review of the literature.Infect Dis Obstet Gynecol,1997,5:326-335.
[15] Clinical Effectiveness Group.National guideline for the management of trichomonas vaginalis.Sex Transm Infect,1999,75(Suppl 1):S21-S23.
[16] Clinical Effectiveness Group.National guideline for the management of bacterial vaginosis.Sex Transm Infect,1999,75(Suppl 1):S16-S18.
[17] Hart G.Risk profiles and epidemiologic interrelationships of sexually transmitted diseases.Sex Transm Dis,1993,20(3):126-136.
[18] McGregor JA,French JI.Bacterial vaginosis in pregnancy.Obstet Gynecol Surv,2000,55(5 Suppl 1):S1-S19.
[19] Clinical Effectiveness Group.National guideline for the management of anogenital warts.Sex Transm Infect,1999,75(Suppl1):S71-S75.
[20] Laboratory Centre for Disease Control.Canadian STD Guidelines.Ottawa:Health Canada,1998:191-200.